We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon

News   Jan 25, 2012

 
Boehringer Ingelheim Prolongates Drug Discovery Collaboration with Priaxon
 
 
Advertisement
 

RELATED ARTICLES

Placebos Prove Powerful, Even When People Know They're Taking One, New Study Suggests

News

Researchers have demonstrated that placebos reduce brain markers of emotional distress even when people know they are taking one.

READ MORE

Recreating Nature: Chemists Create Synthetic Version of Natural Anti-Cancer Agent

News

Scripps Research chemists Hans Renata, PhD, and Alexander Adibekian, PhD, have discovered a way to efficiently create a synthetic version of a valuable natural compound called cepafungin I, which has shown promise as an anti-cancer agent.

READ MORE

New Insights Into How Ovarian Cancer Grows and Evolves

News

In a paper published in the journal Cancer Research, researchers provide new insights into how ovarian cancer grows and evolves within a person.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE